Recombinant Pseudomonas Exotoxins
Company
Bristol-Myers Squibb Company
Use
Used to target the Lewis-Y antigen for therapeutic and diagnostic purposes
Features
The first active immunotoxin with low side effects
NIH Contribution
Developed the recombinant pseudomonas exotoxin
HHS Institute/Agency
NCI
Inventor(s)
I. Pastan, D. Fitzgerald
Year
1996
Tech Cat
Research Reagent
![L-326-1991 L-326-1991](/sites/default/files/styles/large/public/images/showcase/29337/pseudomonas-exotoxins-64.jpg?itok=ew4dVCBK)